Abstract 1999: Diagnostic utility of the NETest in neuroendocrine transformed prostate cancer
Abstract
Background: Neuroendocrine differentiation and the development of an aggressive phenotype are key features of castration-resistant prostate cancer (CRPC) disease. Current blood-based biomarkers cannot detect these treatment-refractory cancer variants. Aims: Evaluate the utility of the NETest, a blood-based 51-marker gene neuroendocrine detection tool, as a CRPC diagnostic and examine which functional gene clusters (hallmarks) differentiate CRPC...
Paper Details
Title
Abstract 1999: Diagnostic utility of the NETest in neuroendocrine transformed prostate cancer
Published Date
Aug 15, 2020
Journal
Volume
80
Issue
16_Supplement
Pages
1999 - 1999
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History